Related Experiment Video
Updated: Jan 10, 2026
05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
10.1K
Quality Indicators for Drug Dispensing in Community Pharmacies: A Scoping Review Protocol
Lara Joana Santos Caxico-Vieira1, Elindayane Vieira de Souza1, Maria Amélia Joyce da Silva Moura1
1Graduate Program in Health Sciences, Laboratory of Teaching and Research in Social Pharmacy (LEPFS), Department of Pharmacy, Federal University of Sergipe, São Cristóvão, Sergipe, Brazil.
Journal of Evaluation in Clinical Practice
|November 28, 2025
Summary
This scoping review identifies validated quality indicators for drug dispensing in community pharmacies. It aims to standardize practices for safer and more effective pharmaceutical care.
Area of Science:
- Pharmaceutical Sciences
- Health Services Research
Background:
- Assessing health service quality through indicators is crucial for improvement and accountability.
- A gap exists in the literature regarding comprehensive measurement of drug dispensing quality.
Purpose of the Study:
- To identify validated indicators for assessing drug dispensing quality in community pharmacies.
- To provide a comprehensive overview of current measurement practices.
Main Methods:
- Scoping review following JBI Reviewer's Manual and PRISMA-ScR guidelines.
- Systematic electronic searches in major databases (PubMed, Embase, Scopus, Web of Science, LILACS).
- Independent data extraction and narrative synthesis by multiple reviewers.
Main Results:
- Identification of validated quality indicators for drug dispensing.
- Critical analysis of the identified indicators.
- Synthesis of findings to bridge fragmented practices with evidence-based standards.
Conclusions:
- This review will establish a foundation for evidence-based standards in pharmaceutical care.
- The findings will guide safer and more effective drug dispensing practices in community pharmacies.
- It addresses the need for standardized quality assessment in pharmaceutical services.
More Related Videos
Related Concept Videos
01:28Dosage Regimens: Designs and Approaches
242
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
242
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
135
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
135
01:24Dosage Regimen: Individualization
154
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
154
01:19Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
01:15Drug Dosing: Geriatric Patients
212
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
212
01:29Clinically Relevant Drug Product Specifications: Methods of Establishment
186
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
186